Investing

Abbott Laboratories : ABT

ABT

Stock Data

$101.31

$0.35 (0.34%)

Asset Type

Common Stock

Exchange

NYSE

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

MEDICAL DEVICES

Abbott Laboratories is a global healthcare company with a broad portfolio of products across various segments, including pharmaceuticals, diagnostics, nutritional products, and medical devices. Founded in 1888 and headquartered in North Chicago, Illinois, Abbott is known for its innovative solutions in managing health conditions such as diabetes, cardiovascular diseases, and chronic pain. It also offers a range of diagnostics equipment and tests for infectious diseases, including HIV and influenza, as well as nutritional products for both pediatric and adult patients. Abbott's commitment to improving lives is evident through its diverse offerings aimed at enhancing health and well-being worldwide.

Latest Activity

Jim Cramer@jimcramer

Jul 16, 2:15pm ET

The CNBC host signals momentum names he favors heading into the next session, flagging Abbott and UnitedHealth as names with near-term upside left.

Of the big "ups" i think that Abbott and UNH could have more support tomorrow

• Replies28
• Reposts3
• Likes62

Activity card posted 2026-07-16T18:15:33.000Z

ShareRead more

ABTAbbott Laboratories

Q2 2026

Jul 16, 7:36am ET

EPS

$1.31

est $1.28+2.6%

Revenue

$12.59B

est $12.52B+0.6%

Abbott beat on adjusted EPS and raised full-year guidance to $5.45 to $5.60 as the Exact Sciences acquisition fueled a 13% revenue surge, though continuous glucose monitor competition and a declining Nutrition business keep near-term headwinds in play.

ShareRead more

All Abbott Laboratories Articles

319 Articles

Vandita Jadeja | 1 minute ago

Johnson & Johnson vs Abbott Laboratories: Two Healthcare Giants on Opposite Trajectories

JNJ is pruning its portfolio while Abbott just dropped $21 billion to expand into cancer diagnostics, and the two strategies…

Trey Thoelcke | Jul 16, 2026 at 7:40 AM EDT

What Investors Don’t Understand About Abbott Laboratories

Wall Street still prices Abbott like a slow-and-steady dividend stalwart, but a pair of massive strategic moves beneath the surface…

Alex Sirois | Jul 13, 2026 at 4:47 PM EDT

Abbott Labs Vs. Pfizer: Which Discounted Healthcare Titan Screens as the Bigger Value Trap?

Abbott is down nearly 23% this year while Pfizer dangles a 7% yield, and both just beat Q1 estimates. One…

Alex Sirois | Jul 10, 2026 at 2:18 PM EDT

Abbott Labs Vs. Danaher: Abbott’s Everyday Products Beat Danaher’s Slumping Biotech Equipment

Abbott and Danaher both reported Q1 2026 results, but the businesses underneath those numbers point in opposite directions, and choosing…

Lee Jackson | Jul 2, 2026 at 8:18 AM EDT

5 Underperforming Dividend Kings Offer Big Passive Income and Huge Total Return Potential

Passive income is characterized by its ability to generate revenue without requiring the earner’s continuous active effort, making it a…

Lee Jackson | Jul 1, 2026 at 8:03 AM EDT

Here Are Wednesday’s Best Wall Street Analyst Research Calls: Abbott Laboratories, Circle Internet, Dow, Kratos Defense, Lockheed Martin, Salesforce, ServiceNow,SpaceX, and More

Pre-Market Stock Futures: Futures are trading lower as we get ready to start the third quarter after a record-setting second…

Alex Sirois | Jun 25, 2026 at 2:20 PM EDT

Buy, Hold, or Sell: Tech Compression Dragged Abbott Labs Under $91, but 1 Massive Diabetes Catalyst Makes It a Screaming Buy

Abbott Laboratories (NYSE:ABT | ABT Price Prediction) at $90.53 is a Buy. The healthcare giant has been swept up in…

Alex Sirois | Jun 24, 2026 at 1:36 PM EDT

Got $2,500? 1 Unstoppable Dividend Aristocrat With an Ironclad Moat to Buy

Abbott Laboratories (NYSE:ABT | ABT Price Prediction) is a stock with characteristics suited to multi-decade ownership, because its four-segment healthcare…

Lee Jackson | Apr 22, 2026 at 7:58 AM EDT

Here Are Wednesday’s Top Wall Street Analyst Research Calls: Abbott Laboratories, Airbnb, Biogen, Cava Group, GitLab, Halliburton, Qualcomm, Seagate, Toast, and More

Pre-Market Stock Futures: Futures are trading higher as we hit the midweek point. All major indices finished lower on Tuesday…

Trey Thoelcke | Apr 21, 2026 at 11:20 AM EDT

Wall Street Refuses to Blink: 2 Healthcare Stocks at 52-Week Lows That Analysts Still Love

Boston Scientific (NYSE: BSX | BSX Price Prediction) trades around $61, with analyst price targets ranging from $69 (conservative) to…

Trey Thoelcke | Apr 20, 2026 at 7:05 AM EDT

Has the Abbott Laboratories Sell-Off Finally Created an Entry Point?

Whether Abbott Laboratories (NYSE: ABT | ABT Price Prediction) stock is at a good entry point depends on your investment…

Vandita Jadeja | Apr 17, 2026 at 7:49 AM EDT

Abbott Price Prediction: Where Will the Stock Be in 2027

Abbott Laboratories (NYSE: ABT | ABT Price Prediction) has pulled back sharply in 2026. Our Wall St. price target for…

Joel South | Mar 11, 2026 at 10:25 AM EDT

Intuitive Surgical Upgraded to Buy by Citi — Plus Key Moves on Stryker and Abbott

Citi is making a clear statement about the health of U.S. medical technology heading into the spring: the sector’s fundamentals…

Lee Jackson | Mar 11, 2026 at 8:10 AM EDT

Hope for the Best and Plan for the Worst: The 5 Safest Dividend Aristocrats

The stock market could face serious trouble in 2026 as extreme valuations collide with geopolitical tensions, AI investment skepticism, and…

Joel South | Feb 12, 2026 at 1:04 PM EST

Abbott Labs Just Extended Its Dividend Aristocrat Status: What Comes Next?

Abbott Laboratories just paid its quarterly dividend of $0.63 per share on February 13, 2026, marking a 6.8% increase from…